The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)

Area of Science:

• Public Health
• Genetics
• Pediatrics

Background:

• Brazil's National Neonatal Screening Program (NNSP) established in 2001 covers all states.
• The NNSP screens for six diseases, including sickle cell disease (SCD) and hemoglobinopathies.
• Program coverage reached 80% of live births in 2005 and has since ranged between 80-84% nationally, with state-level disparities.

Purpose of the Study:

• To assess the organization and effectiveness of Brazil's NNSP for managing diagnosed conditions, particularly SCD.
• To highlight challenges and achievements in integrating neonatal screening with public health network (SUS) services.
• To outline goals for comprehensive SCD patient care, focusing on information, prevention, and integrated health promotion.

Main Methods:

• Review of the implementation and coverage of the NNSP since 2001.
• Analysis of Ministry of Health guidelines for clinical follow-up and treatment.
• Examination of efforts to organize the public health network (SUS) for patient care.

Main Results:

• Significant progress in establishing a public health network (SUS) for neonatal screening follow-up.
• Integration of scientific and technological advancements into treatment protocols.
• Ongoing challenges in organizing a comprehensive care network for SCD patients.

Conclusions:

• Brazil's NNSP has made considerable gains in screening for SCD and other hemoglobinopathies.
• Organizing the SUS for comprehensive, integrated care remains a key challenge.
• Future goals focus on enhancing professional and patient education, preventing complications, and improving quality of life for SCD patients.